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Whole exome sequencing is a technique that aims to selectively sequence all exons of protein-coding genes.
A canine whole exome sequencing enrichment kit was designed based on the latest canine reference genome
(build 3.1.72). Its performance was tested by sequencing 2 exome captures, each consisting of 4 pre-capture
pooled, barcoded Illumina libraries on an Illumina HiSeq 2500. At an average sequencing depth of 102x, 83
to 86% of the target regions were completely sequenced with a minimum coverage of five and 90% of the
reads mapped on the target regions. Additionally, it is shown that the reproducibility within and between
captures is high and that pooling four samples per capture is a valid option. Overall, we have demonstrated
the strong performance of this WES enrichment kit and are confident it will be a valuable tool in future
disease association studies.
S
ince the first reported study onWhole Exome Sequencing (WES) in 20071, well over 2000 papers have been
published applying this technique (PubMed search: ‘‘exome sequencing’’). WES is a cost-efficient approach
to selectively sequence the coding regions of the genome. This approach allows to identify most functional
variation without the high costs associated with whole-genome sequencing (WGS). Unfortunately, predesigned
and validated kits are only commercially available for human and mouse. Scientific reports of WES on other
animals are scarce2–4. This is unfortunate, as for example the dog is an excellent animal model for comparative
disease genetics5. To fill the gap, we designed a canine exome sequencing kit (based on build 3.1.72) and tested its
performance using Illumina Sequencing.
Results
Design. We designed a canine whole exome sequencing enrichment kit based on the latest canine reference
genome (Broad CanFam 3.1.72)6. This design was based on the combination of the Ensembl Genes, the RefSeq
Genes and the mRNA annotation. Additionally, known microRNAs were added from miRBase. After merging
overlapping regions, the total size of the design was 52,876,195 bp (<2% of the genome) divided over 203,059
regions. Based on our design, capturing baits were developed by Roche Nimblegen to target the specific regions.
To avoid toomuch off-target sequencing, themost stringent setting was chosen for the baits design, allowing only
unique matches from each bait to the reference genome.
Performance: coverage and specificity. To assess the performance of the WES enrichtment kit, two exome
captures were done, each consisting of 4 pooled samples. Sequencing depth, coverage of targeted regions and
targeted bases and specificity were assessed for every sample. The results are reported for a minimum coverage of
one and five (as five was the threshold used for variant calling). Each capture library was sequenced in one
Illumina HiSeq 2500 lane. The number of raw reads generated per sample varied between 74,657,388 and
111,624,766. After quality trimming, mapping and duplicate read removal, between 87% and 90% of the reads
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were retained (Table 1). The average sequencing depth overall was
102x and ranged from 82.6x to 125.1x (Table 1).
Overall, an average of 92% of the regions were covered by at least
one read and 90% by at least five reads. At a minimum coverage of
one, 89 to 90% of the regions in our design, were completely covered.
83 to 86% of the regions were completely covered when a minimum
coverage of five was applied (Figure 1). A clear relationship exists
between the percentage of each region being sequenced and the
proportion of total regions being sequenced (Figure 1). On average,
a minimum coverage of 5 was not consistently reached throughout
the entire region for 15% of the regions (Table 2). However, for only
8% of the regions on average, themaximum coverage never reached 5
(Table 2).
When looking at the coverage of targeted bases instead of regions,
93 to 94% (<49 Mb) of the targeted bases (<53 Mb) were covered at
least once and 89 to 91% were covered at least five times (Table 3).
We also assessed the specificity (reads on target/total number of
reads). With an average overall specificity of 90%, off-target sequen-
cing is rather small and comparable with earlier reports7. The spe-
cificity was also assessed in every single sample per chromosome. For
all eight samples, results were similar, with the highest specificity on
average found on chromosome nine (94.05%) and the lowest specifi-
city found on average on chromosome 22 (84.09%). Per chromosome
specificity is available in Supplementary Table S1.
Performance: reproducibility. The reproducibility within and
between captures was checked by comparing the amount of
targeted bases and regions that are sequenced at least once and five
times in every single sample. Overall, from the <53 Mb target base
pairs, 48,141,464 base pairs (91.0%) were sequenced at least once in
all eight samples. We also assessed how many base pairs were never
sequenced. Overall, 2,313,892 base pairs (4.4%) were never covered.
Overall, the remaining 4.6% of the total target base pairs are being
sequenced variably. Comparing the 4 samples within each capture,
we found that 48,333,432 (91.4%) or 48,663,244 (92.0%) base pairs
were common and 2,816,548 (5.3%) or 2,553,759 (4.8%) base pairs
Table 1 | Statistics for exome sequencing eight dogs
Sequencing reads
Sample Total Mapped Duplicate Remaining Remaining (%) Sequencing depth (x)
1 82,574,410 77,392,469 4,820,648 72,571,821 87.9 93.0
2 74,657,388 69,542,653 4,518,820 65,023,833 87.1 82.6
3 90,534,096 83,841,822 4,680,806 79,161,016 87.4 102.0
4 77,786,110 72,147,586 4,457,341 67,690,245 87.0 87.1
5 111,624,766 108,781,536 9,882,797 98,898,739 88.6 125.1
6 96,041,166 93,261,066 8,278,081 84,982,985 88.5 106.9
7 103,290,412 100,440,603 8,653,736 91,786,867 88.9 116.7
8 86,094,438 83,226,207 5,926,249 77,299,958 89.8 99.3
Figure 1 | Relation between the proportion of each region being sequenced and the total amount of regions sequenced (%). For each individual
region per sample, the percentage of the region being sequenced at a minimum coverage of 5, was calculated. On average 85% of the regions were
completely sequenced. This number increased to 87% of the regions being sequenced for at least 90%. Around 90% of the regions were being sequenced
for at least 60%.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 4 : 5597 | DOI: 10.1038/srep05597 2
were never sequenced. A similar analysis was conducted for a
coverage of 5. For all eight samples, 46,236,131 base pairs (87.4%)
were sequenced consistently with a minimum coverage of 5 and
4,078,886 base pairs (7.7%) never reached a coverage of 5.
46,439,217 (87.8%) or 47,102,104 (89.1%) and 4,572,396 (8.6%) or
4,216,408 (8.0%) base pairs were common within each pool reaching
a coverage of at least 5 or never reaching a coverage of 5, respectively.
The regions in common were also assessed for a coverage of 1 and
5. From the 203,059 regions, overall, 4,791 (2.4%) regions were never
sequenced and 176,645 (87,0%) were consistently covered at least
once. Within each pool, 177,664 (87.5%) or 179,463 (88.4%) regions
were common and 6,620 (3.3%) or 5,722 (2.8%) regions were never
sequenced. For a coverage of 5, 11,691 regions (5.8%) were consis-
tently not sequenced sufficiently and 160,366 (79.0%) regions were.
This results in 31,002 (15.3%) of the regions being variably
sequenced. Within each pool for a coverage of 5, 162,312 (79.9%)
or 167,830 (82.7%) reqions were sequenced and 13,484 (6.6%) or
12192 (6.0%) regions were not. The non-covered base pairs and
regions are probably a consequence of the chosen stringency when
baits were designed as only unique matches were allowed. A table
containing these annotated 11,691 regions is available on request.
Sample pooling. Pooling several samples together prior to capturing
is common practice, mainly to reduce cost. Of course, pre-capture
pooling should only be done when it does not significantly decrease
the enrichment performance. To check the effect of pre-capture
pooling, we created subsets containing 25% randomly chosen reads
out of the total number of reads in the combined output of the 4
samples per capture. The rationale is to simulate samples as if they
were not barcoded and as if theDNA strands presented to the capture
baits are from one sample. A random subset of 25% needs to be taken
to reduce the total number of reads to a number comparable to the
number of reads in the individual barcoded samples. Per pool, ten
subsets were created, resulting in a total of twenty new samples.
Comparing the number of regions that are completely covered at
least once in the subsets and the original samples, an average of
687 and 684 additional regions (<0.3%) were covered in the
subsets of pool one and two, respectively. An average of 119,097
and 131,774 additional target base pairs were covered at least once
in the respective subsets, which represents 0.2% of the <53 Mb
design. At a minimum sequencing depth of 5, an average of 1,705
(0.8%) and 1,468 (0.7%) additional completely covered regions and
an additional 174,070 (0.3%) and 164,522 (0.3%) base pairs were
covered for pool one and two, respectively. The average specificity
increased from 90.85% to 91.48% and from 89.86% to 90.73% in both
pools, respectively. Based on these results, we conclude that pre-
capture pooling of samples is a valid option as the effect on the
different performance parameters is minimal. The exact number of
samples that can be pooled, depends on a cost-benefit assessment.
Variant calling. Finally, we also called variants using a probabilistic
variant caller. The number of non-reference variants called per
sample, ranged from 55,683 to 60,576 and from 62,117 to 67,890
with the ‘‘require presence in both forward and reverse reads’’
setting being applied or not, respectively (Supplementary Table
S2). Applying this setting might exclude variants at the boundaries
of the targeted regions, however it decreases the amount of erroneous
variants8.
Discussion
This study is the first to report on the performance of an exome kit
designed for the dog on the latest annotation (CanFam 3.1.72). With
on average 90% of the regions and 90% of the bases covered five
times, a high amount of the targeted regions is captured, without
too much off-target sequencing as the specificity is 90%. The repro-
ducibility within and between captures is high. Additionally, the
results indicate that pooling four samples per capture is a valid option
as it has only a very limited effect on the performance, but substan-
tially reduces the costs. This makesWES evenmore affordable (com-
pared with WGS). Finally, it is demonstrated that WES is capable to
detect variants within the coding regions. Overall, we have demon-
strated the strong performance of this WES enrichment kit and are
confident it will be a valuable tool in future disease association
studies.
Methods
Sample collection. Eight blood samples were obtained from a canine blood bank
available at Ghent University to study genetic disorders9. Approval was granted by the
local ethical (Faculty of Veterinary Medicine, Ghent University, Belgium) and
deontological (Federal Public Service Health, Food Chain Safety and Environment,
Brussels, Belgium) committees (EC2013_193).
Design. The data needed to design the exome kit was downloaded from the
University Of California Santa Cruz (UCSC) (http://genome.ucsc.edu/) table browser
(Dog, CanFam3.1)10. From the Genes and Gene prediction tracks, RefSeq Genes and
Ensembl Genes were selected. The output format was a BED file with the setting
‘‘exons (plus 0 bases at each end)’’. From the mRNA and EST Tracks, Dog mRNAs
and all_mrna were selected respectively. The output format was also a BED file with
the ‘‘blocks plus 0 bases at each end’’ setting. Micro RNA sequence positions were
downloaded from miRBase11. Regions were merged using bedtools version v2.17.0.
The total size of the design was 52,876,195 Mb (<2% of the genome) divided over
203,059 regions. The BED file is available on request.
Roche Nimblegen WES enrichment kit. Our design was processed by the Roche
Nimblegen custom design group (Madison, USA). Using an SSAHA algorithm,
capturing baits were developed based on our design and the reference genome of the
dog (Canis Familiaris 3.1). Design settings for the baits allowed five or fewer single-
base insertions, deletions or substitutions between the baits and the genome. Each bait
itself was only allowed to match one location in the genome to avoid too much off
target sequencing. Regions under 100 bpwere padded to 100 bp to increase capturing
efficiency. After approval, the baits were generated and provided as SeqCap
Developer Library.
DNA extraction. Genomic DNA was extracted with the DNeasy Blood & Tissue Kit
(QIAGEN) with 100 ml of blood as input. The standard protocol was followed with
the exception of the final elution step: instead of using 200 ml of Buffer AE, only 50 ml
was used. The eluate was used again to elute a second and third time to increase the
concentration. The DNA yield was measured with Quant-iTTM PicogreenH dsDNA
Assay (Life Technologies).
Table 2 | Regions with a coverage below 5
Sample
Regions with minimum
coverage ,5 (%)
Regions with maximum
coverage ,5 (%)
1 31,604 (15.56) 16,330 (8.04)
2 33,167 (16.33) 17,042 (8.39)
3 30,122 (14.83) 15,800 (7.78)
4 34,655 (17.07) 17,831 (8.78)
5 28,250 (13.91) 14,733 (7.26)
6 28,979 (14.27) 14,824 (7.30)
7 28,487 (14.03) 14,696 (7.24)
8 30,224 (14.88) 15,465 (7.62)
Table 3 | Coverage of targeted base pairs
Sample % of target bp covered (.1x) % of target bp covered (.5x)
1 93.15 89.96
2 92.90 89.54
3 93.22 90.24
4 92.82 89.15
5 93.52 90.63
6 93.66 90.71
7 93.53 90.63
8 93.56 90.53
The second and third column show the percentage of base pairs from the design of 52,876,195
basepairs with a coverage of at least one and five, respectively, within each sample.
www.nature.com/scientificreports
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Sample preparation and sequencing. Extracted DNA was fragmented on a Covaris
S2 System in a 50 ml volume (aim: 300 bp fragments, settings: duty cycle: 10%,
intensity: 5, cycles per burst: 200, time: 50 s). After shearing, another picogreen assay
was performed. Around one mg of the fragmented DNA was used as input for the
library preparation. Samples were end repaired, A-tailed and ligated with TruSeq
adapters using the reagents from the NEBNext DNA Library Prep Master mix set for
Illumina (New England Biolabs) according to the manufacturer’s protocol. AMPure
XP beads (Beckman Coulter) were used for selection of fragments with an insert size
around 300 bp. One ml of the ligated product was subsequently amplified in an
enrichment PCR (10 cycles) for library quality assessment as recommended in the
‘SeqCap EZ Library SR User’s Guide’ (Nimblegen, Roche). Thereafter, the pre-
capture LM-PCR was performed on the samples for 8 cycles as prescribed in the
SeqCap EZ library protocol. The concentration of each PCR product was determined
using Quant-iTTM PicogreenH dsDNA Assay (Life Technologies). Two times four
samples were equimolarly pooled to obtain a total DNA input of 1250 ng. The pooled
library was hybridized for 67–68 hours with the baits (SeqCap Developer Library).
The hybridized library was washed and the captured and pooled DNAwas recovered.
After a final amplification (LM-PCR, 18 cycles), the quality of the library was checked
using the High Sensitivity DNA chip (Agilent).
QPCR. To check the fold enrichment after capturing, a qPCR is performed as a final
quality control step before sequencing. We chose to test five loci. Primer one is the
standard primer provided by Roche Nimblegen (NSC-0237). The other four primers
were designed using NCBI Primer-BLAST (http://www.ncbi.nlm.nih.gov/tools/
primer-blast/)12. Sequences are available in Supplementary Table S3. The
amplification efficiency of each primer was determined by qPCR. One ml of the
following template DNA quantities were added to each reaction: 20 ng, 10 ng, 5 ng,
2.5 ng and 1.25 ng. Each reaction was performed in triplicate. Efficiencies E were
calculated with the following formula: E5 10(–1/slope of standard curve) and are mentioned in
Supplementary Table S3. To assess the fold enrichment for both pools of four
samples, a qPCR was performed according to the instructions from Roche
Nimblegen. Fold enrichment was calculated using the following formula: (Edelta-Ct)
with delta-Ct being the difference in threshold cycle between the library prior and
post capturing. The average fold enrichment was well over the tenfold threshold
suggested by Roche Nimblegen.
Sequencing. The two pools were sequenced on two different lanes in two different
runs on a HiSeq 2500 PE 100 bp.
Data-analysis.Data-analysis was performed using the CLC Genomics Workbench
(Version 6.5.1, CLC Bio, Aarhus, Denmark). Data was trimmed with the following
settings: ambiguous trim 5 no, quality trim 5 yes, quality limit 5 0.05, use
colorspace 5 no, create report 5 yes, also search on reversed sequence 5 yes, save
discarded sequences 5 yes, remove 59 terminal nucleotides 5 no, discard short
reads 5 no, remove 39 terminal nucleotides 5 no, trim adapter list 5 adapter list
Illumina, discard long reads 5 no, save broken pairs 5 yes. The reference genome
was downloaded from the UCSC genome browser6. For read mapping, the
following parameters were used: mismatch cost 5 2, insertion and deletion cost 5
3, length fraction: 0.5, similarity fraction 5 0.8, global alignment 5 no, auto-
detect paired distances 5 yes, non-specific match handling 5 ignore, output
mode 5 create reads track, create report 5 yes, collect un-mapped reads 5 yes.
Duplicated reads were removed with the Duplicate Mapped Reads Removal
(Version 1.0 beta 5) plugin (setting: maximum representation of minority
sequence (percent) to 20.0). Reads were locally realigned with the following
settings: realign unaligned ends 5 yes, multi-pass realignment 5 3, guidance-
variant track 5 not set, output mode 5 create reads track, output track of
realigned regions 5 yes. Variants were called twice using probability variant
detection with the following settings: ignore non-specific matches 5 yes, ignore
broken pairs 5 yes, minimum coverage 5 5, variant probability 5 90.0, required
variant count 5 2, ignore variants in non-specific regions 5 yes, filter 454/Ion
homopolymer indels 5 no, maximum expected variants 5 2, genetic code 5 1
standard, create track 5 yes, create annotated table 5 yes. The first variants were
called with the ‘‘require presence in both forward and reverse reads 5 yes’’, the
second call was run without this setting.
Effect of pooling. Forward and reverse reads from each pool were combined in two
large pools. From each pool, ten random subsets were created using seqtk version 1.0-
r31. Data was analysed using the same settings as the real samples.
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